Long-Term Exposure of Fresh and Aged Nano Zinc Oxide Promotes Hepatocellular Carcinoma Malignancy by Up-Regulating Claudin-2
International Journal of Nanomedicine · 2024
DOI: 10.2147/ijn.s478279 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Na Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, School of Basic Medical Science, Anhui Medical University, Hefei, 230032, People's Republic of China. Hauptthemen laut MEDLINE: Zinc Oxide, Carcinoma, Hepatocellular, Liver Neoplasms, Mice, Nude. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Tumor development and progression is a long and complex process influenced by a combination of intrinsic (eg, gene mutation) and extrinsic (eg, environmental pollution) factors. As a detoxification organ, the liver plays an important role in human exposure and response to various environmental pollutants including nanomaterials (NMs). Hepatocellular carcinoma (HCC) is one of the most common malignant tumors and remains a serious threat to human health. Whether NMs promote liver cancer progression remains elusive and assessing long-term exposure to subtoxic doses of nanoparticles (NPs) remains a challenge. In this study, we focused on the promotional effects of nano zinc oxide (nZnO) on the malignant progression of human HCC cells HepG2, especially aged nZnO that has undergone physicochemical transformation.
Methods
In in vitro experiments, we performed colony forming efficiency, soft agar colony formation, and cell migration/invasion assays on HepG2 cells that had been exposed to a low dose of nZnO (1.5 μg/mL) for 3 or 4 months. In in vivo experiments, we subcutaneously inoculated HepG2 cells that had undergone long-term exposure to nZnO for 4 months into BALB/c athymic nude mice and observed tumor formation. ZnCl2 was administered to determine the role of zinc ions.
Results
Chronic low-dose exposure to nZnO significantly intensified the malignant progression of HCC cells, whereas aged nZnO may exacerbate the severity of malignant progression. Furthermore, through transcriptome sequencing analysis and in vitro cellular rescue experiments, we demonstrated that the mechanism of nZnO-induced malignant progression of HCC could be linked to the activation of Claudin-2 (CLDN2), one of the components of cellular tight junctions, and the dysregulation of its downstream signaling pathways.
Conclusion
Long-term exposure of fresh and aged nZnO promotes hepatocellular carcinoma malignancy by up-regulating CLDN2. The implications of this work can be profound for cancer patients, as the use of various nanoproducts and unintentional exposure to environmentally transformed NMs may unknowingly hasten the progression of their cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, School of Basic Medical Science, Anhui Medical University, Hefei, 230032, People's Republic of China.
- Department of Public Health Inspection and Quarantine, School of Public Health, Anhui Medical University, Hefei, 230032, People's Republic of China.
ORCID-Profile: Meimei Wang
Zitieren
APA
Yu, N., Su, M., Wang, J., Liu, Y., Yang, J., Zhang, J., & Wang, M. (2024). Long-Term Exposure of Fresh and Aged Nano Zinc Oxide Promotes Hepatocellular Carcinoma Malignancy by Up-Regulating Claudin-2. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s478279
Vancouver
Yu N, Su M, Wang J, Liu Y, Yang J, Zhang J, et al. Long-Term Exposure of Fresh and Aged Nano Zinc Oxide Promotes Hepatocellular Carcinoma Malignancy by Up-Regulating Claudin-2. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s478279
BibTeX
@article{Yu2024,
author = {Yu, Na and Su, Mingqin and Wang, Juan and Liu, Yakun and Yang, Jingya and Zhang, Jingyi and Wang, Meimei},
title = {Long-Term Exposure of Fresh and Aged Nano Zinc Oxide Promotes Hepatocellular Carcinoma Malignancy by Up-Regulating Claudin-2},
journal = {International Journal of Nanomedicine},
year = {2024},
doi = {10.2147/ijn.s478279}
}
EUVIMED